BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ablynx 

Technologiepark 4

Ghent  Zwijnaarde  9052  Belgium
Phone: 32-0-9-261-06-32 Fax: 32-0-9-261-06-28


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Ablynx (ABLYF) Announces Warrant Exercise 7/18/2014 6:23:48 AM
Euronext Introduces Spotlight Options On Ablynx (ABLYF) 7/15/2014 6:10:45 AM
Ablynx (ABLYF) Release: Publication In Accordance With Article 14 Of The Belgian Law Of 2 May 2007 Regarding The Publication Of Major Shareholdings (The "Transparency Law") 5/20/2014 11:56:36 AM
Ablynx (ABLYF) Announces Q1 2014 Business Update 5/14/2014 9:08:29 AM
Ablynx (ABLYF), Merck & Co., Inc. (MRK) Forge Cancer Pact Worth $2.3 Billion 2/3/2014 6:56:21 AM
Ablynx (ABLYF) To Present At The 32nd Annual J.P. Morgan Healthcare Conference And To Provide An Update On Its TTP Program 1/13/2014 12:15:22 PM
Ablynx (ABLYF) Provides Business Update For The First Nine Months Of 2013 11/14/2013 9:37:59 AM
Ablynx (ABLYF) Announces Update on Anti-RSV Nanobody Programme and Receives Grant Funding for Further Development 10/31/2013 10:21:14 AM
Ablynx (ABLYF) Partner Boehringer Ingelheim Corporation Initiates Phase 1 Study With Nanobody to Treat Alzheimer's Disease 10/29/2013 9:31:25 AM
Ablynx (ABLYF) to Present Pre-clinical Proof-of-Concept Data on ALX-0761 at American College of Rheumatology 10/28/2013 9:49:47 AM
12345678910...